Literature DB >> 24893782

Epstein-Barr virus, the germinal centre and the development of Hodgkin's lymphoma.

Ghada Mohamed1, Katerina Vrzalikova1, Fathima Zumla Cader1, Martina Vockerodt1, Eszter Nagy1, Patrik Flodr2, Lee-Fah Yap3, Arjan Diepstra4, Philip M Kluin4, Stefano Rosati4, Paul Murray1.   

Abstract

The relationship between Epstein-Barr virus (EBV) and the germinal centre (GC) of the asymptomatic host remains an enigma. The occasional appearance of EBV-positive germinal centres in some patients, particularly those with a history of immunosuppression, suggests that EBV numbers in the GC are subject to immune control. The relationship, if any, between lymphoid hyperplasia with EBV-positive germinal centres and subsequent or concurrent lymphomagenesis remains to be clarified. As far as the development of EBV-associated Hodgkin's lymphoma is concerned, the suppression of virus replication, mediated by LMP1 on the one hand, and the loss of B-cell receptor signalling on the other, appears to be an important pathogenic mechanism. A further important emerging concept is that alterations in the microenvironment of the EBV-infected B-cell may be important for lymphomagenesis.
© 2014 The Authors.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24893782      PMCID: PMC7346593          DOI: 10.1099/vir.0.066712-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  67 in total

1.  Evidence of the intersection of Epstein-Barr virus with germinal center.

Authors:  Paloma Martín; Maria José Coronado; Carmen Bellas
Journal:  APMIS       Date:  2011-11-11       Impact factor: 3.205

2.  Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease.

Authors:  L M Weiss; L A Movahed; R A Warnke; J Sklar
Journal:  N Engl J Med       Date:  1989-02-23       Impact factor: 91.245

Review 3.  Germinal centers.

Authors:  I C MacLennan
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

4.  Latent membrane protein 1 inhibits Epstein-Barr virus lytic cycle induction and progress via different mechanisms.

Authors:  Stuart Prince; Sinead Keating; Ceri Fielding; Paul Brennan; Eike Floettmann; Martin Rowe
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

5.  Epstein-Barr virus (EBV) in infectious mononucleosis: detection of the virus in tonsillar B lymphocytes but not in desquamated oropharyngeal epithelial cells.

Authors:  G Niedobitek; A Agathanggelou; N Steven; L S Young
Journal:  Mol Pathol       Date:  2000-02

6.  Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule.

Authors:  O Gires; U Zimber-Strobl; R Gonnella; M Ueffing; G Marschall; R Zeidler; D Pich; W Hammerschmidt
Journal:  EMBO J       Date:  1997-10-15       Impact factor: 11.598

7.  Epstein-Barr virus infection in vitro can rescue germinal center B cells with inactivated immunoglobulin genes.

Authors:  Sridhar Chaganti; Andrew I Bell; Noelia Begue Pastor; Anne E Milner; Mark Drayson; John Gordon; Alan B Rickinson
Journal:  Blood       Date:  2005-08-25       Impact factor: 22.113

8.  Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4A and p14ARF expression.

Authors:  Seiji Maruo; Bo Zhao; Eric Johannsen; Elliott Kieff; James Zou; Kenzo Takada
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-18       Impact factor: 11.205

9.  Quantitative studies of Epstein-Barr virus-encoded microRNAs provide novel insights into their regulation.

Authors:  Richard Amoroso; Leah Fitzsimmons; Wendy A Thomas; Gemma L Kelly; Martin Rowe; Andrew I Bell
Journal:  J Virol       Date:  2010-11-10       Impact factor: 5.103

10.  B cell receptor signal strength determines B cell fate.

Authors:  Stefano Casola; Kevin L Otipoby; Marat Alimzhanov; Sibille Humme; Nathalie Uyttersprot; Jeffery L Kutok; Michael C Carroll; Klaus Rajewsky
Journal:  Nat Immunol       Date:  2004-02-01       Impact factor: 25.606

View more
  2 in total

1.  EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC.

Authors:  Qijia Yan; Zhaoyang Zeng; Zhaojian Gong; Wenling Zhang; Xiayu Li; Baoyu He; Yali Song; Qiao Li; Yong Zeng; Qianjin Liao; Pan Chen; Lei Shi; Songqing Fan; Bo Xiang; Jian Ma; Ming Zhou; Xiaoling Li; Jianbo Yang; Wei Xiong; Guiyuan Li
Journal:  Oncotarget       Date:  2015-12-08

2.  Differences in Epstein-Barr Virus Characteristics and Viral-Related Microenvironment Could Be Responsible for Lymphomagenesis in Children.

Authors:  Aldana Vistarop; Oscar Jimenez; Melina Cohen; Elena De Matteo; Maria Victoria Preciado; Paola Chabay
Journal:  Pathogens       Date:  2020-01-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.